共 50 条
Structure-activity relationship for the folding intermediate-selective inhibition of DYRK1A
被引:6
|作者:
Miyazaki, Yuka
[1
]
Kikuchi, Masaki
[2
]
Umezawa, Koji
[3
]
Descamps, Aurelie
[4
]
Nakamura, Daichi
[4
]
Furuie, Gaku
[1
]
Sumida, Tomoe
[4
,6
]
Saito, Kanako
[1
]
Kimura, Ninako
[1
]
Niwa, Takashi
[4
]
Sumida, Yuto
[4
,6
]
Umehara, Takashi
[2
]
Hosoya, Takamitsu
[4
,5
]
Kii, Isao
[1
,3
,4
]
机构:
[1] Shinshu Univ, Grad Sch Sci & Technol, Dept Agr, Lab Drug Target Res, 8304 Minami Minowa, Nagano 3994598, Japan
[2] RIKEN, Lab Epigenet Drug Discovery, Ctr Biosyst Dynam Res, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan
[3] Shinshu Univ, Inst Biomed Sci, Dept Biomol Innovat, 8304 Minami Minowa, Nagano 3994598, Japan
[4] RIKEN, Lab Chem Biol, Ctr Biosyst Dynam Res, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
[5] Tokyo Med & Dent Univ TMDU, Inst Biomat & Bioengn, Lab Chem Biosci, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo, Japan
[6] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan
关键词:
DYRK1A;
Folding intermediate;
Autophosphorylation;
FINDY;
Alzheimer's disease;
Down syndrome;
DOWN-SYNDROME CANDIDATE;
PROTEIN-KINASE;
MOUSE MODEL;
MURINE MODEL;
DRUG-TARGET;
CYCLIN D1;
ACTIVATION;
AUTOPHOSPHORYLATION;
OVEREXPRESSION;
REVEALS;
D O I:
10.1016/j.ejmech.2021.113948
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
DYRK1A phosphorylates proteins involved in neurological disorders in an intermolecular manner. Meanwhile, during the protein folding process of DYRK1A, a transitional folding intermediate catalyzes the intramolecular autophosphorylation required for the "one-off" inceptive activation and stabilization. In our previous study, a small molecule termed FINDY (1) was identified, which inhibits the folding intermediate-catalyzed intramolecular autophosphorylation of DYRK1A but not the folded state-catalyzed intermolecular phosphorylation. However, the structural features of FINDY (1) responsible for this intermediate-selective inhibition remain elusive. In this study, structural derivatives of FINDY (1) were designed and synthesized according to its predicted binding mode in the ATP pocket of DYRK1A. Quantitative structure-activity relationship (QSAR) of the derivatives revealed that the selectivity against the folding intermediate is determined by steric hindrance between the bulky hydrophobic moiety of the derivatives and the entrance to the pocket. In addition, a potent derivative 3 was identified, which inhibited the folding intermediate more strongly than FINDY (1); it was designated as dp-FINDY. Although dp-FINDY (3) did not inhibit the folded state, as well as FINDY (1), it inhibited the intramolecular autophosphorylation of DYRK1A in an in vitro cell-free protein synthesis assay. Furthermore, dp-FINDY (3) destabilized endogenous DYRK1A in HEK293 cells. This study provides structural insights into the folding intermediate-selective inhibition of DYRK1A and expands the chemical options for the design of a kinase inhibitor. (C) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:18
相关论文